Biological Properties and Analytical Methods for Micafungin: A Critical Review

References

• Renslo, A. R. The Echinocandins: Total and Semi-Synthetic Approaches in Antifungal Drug Discovery. Anti-Infective Agents Med. Chem. (Formerly ‘Current Med. Chem. - anti-Infective Agents). 2007, 6, 201–212. DOI: 10.2174/187152107781023683.
   Google Scholar
• Leverger, G.; Timsit, J. F.; Milpied, N.; Gachot, B. Use of Micafungin for the Prevention and Treatment of Invasive Fungal Infections in Everyday Pediatric Care in France: Results of the MYRIADE Study. Pediatr. Infect. Dis. J. 2019, 38, 716–721. DOI: 10.1097/INF.0000000000002353.
   PubMed Web of Science ®Google Scholar
• Denning, D. W. Echinocandin Antifungal Drugs. Lancet 2003, 362, 1142–1151. DOI: 10.1016/S0140-6736(03)14472-8.
   PubMed Web of Science ®Google Scholar
• Perlin, D. S. Mechanisms of Echinocandin Antifungal Drug Resistance. Ann. NY. Acad. Sci. 2015, 1354, 1–11. DOI: 10.1111/nyas.12831.
   PubMed Web of Science ®Google Scholar
• Carver, P. L. New Drug Developments. Orthop. Nurs. 2004, 38, 341. 10.1345/aph.1D301.
   Google Scholar
• Chandrasekar, P. H.; Sobel, J. D. Micafungin: A New Echinocandin. Clin. Infect. Dis. 2006, 42, 1171–1178. DOI: 10.1086/501020.
   PubMed Web of Science ®Google Scholar
• Hope, W. W.; Smith, P. B.; Arrieta, A.; Buell, D. N.; Roy, M.; Kaibara, A.; Walsh, T. J.; Cohen-Wolkowiez, M.; Benjamin, D. K. Population Pharmacokinetics of Micafungin in Neonates and Young Infants. Antimicrob. Agents Chemother. 2010, 54, 2633–2637. DOI: 10.1128/AAC.01679-09.
   PubMed Web of Science ®Google Scholar
• Ishikawa, J.; Maeda, T.; Matsumura, I.; Yasumi, M.; Ujiie, H.; Masaie, H.; Nakazawa, T.; Mochizuki, N.; Kishino, S.; Kanakura, Y. Antifungal Activity of Micafungin in Serum. Antimicrob. Agents Chemother. 2009, 53, 4559–4562. DOI: 10.1128/AAC.01404-08.
   PubMed Web of Science ®Google Scholar
• Caselli, D.; Galli, L.; Tondo, A.; Cuzzubbo, D.; Casini, T.; Simone, L.; Di; Tamburini, A.; Bambi, F.; Tucci, F.; Aricò, M. Use of Micafungin for the Management of a Cluster of Invasive Aspergillosis in Children with Cancer. J. Adv. Med. Pharm. Sci. 2019, 20, 1–8. DOI: 10.9734/jamps/2019/v20i330112.
   Google Scholar
• Park, H.; Youk, J.; Shin, D. Y.; Hong, J.; Kim, I.; Kim, N. J.; Lee, J. O.; Bang, S. M.; Yoon, S. S.; Park, W. B.; et al. Micafungin Prophylaxis for Acute Leukemia Patients Undergoing Induction Chemotherapy. BMC Cancer 2019, 19, 1–9. DOI: 10.1186/s12885-019-5557-9.
   PubMed Web of Science ®Google Scholar
• Xhaard, A.; Porcher, R.; Bergeron, A.; Alanio, A.; Touratier, S.; Bretagne, S.; de Margerie-Mellon, C.; Sicre de Fontbrune, F.; Itzykson, R.; Coman, T.; et al. Primary Antifungal Prophylaxis with Micafungin after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Prospective Study. Ann. Hematol. 2019, 98, 1033–1035. DOI: 10.1007/s00277-018-3530-3.
   PubMed Web of Science ®Google Scholar
• Kang, W. H.; Song, G. W.; Lee, S. G.; Suh, K. S.; Lee, K. W.; Yi, N. J.; Joh, J. W.; Kwon, C. H. D.; Kim, J. M.; Choi, D. L.; et al. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients. J. Gastrointest. Surg. 2019, DOI: 10.1007/s11605-019-04241-w.
   Web of Science ®Google Scholar
• Whaley, S. G.; Berkow, E. L.; Rybak, J. M.; Nishimoto, A. T.; Barker, K. S.; Rogers, P. D. Azole Antifungal Resistance in Candida albicans and Emerging Non-Albicans Candida Species. Front. Microbiol. 2017, 7, 1–12. DOI: 10.3389/fmicb.2016.02173.
   Web of Science ®Google Scholar
• Iwamoto, T.; Fujie, A.; Sakamoto, K.; Tsurumi, Y.; Shigematsu, N.; Yamashita, M.; Hashimoto, S.; Okuhara, M.; Kohsaka, M. WF11899A, B and C, Novel Antifungal Lipopeptides. I. Taxonomy, Fermentation, Isolation and Physico-Chemical Properties. J. Antibiot. 1994, 47, 1084–1091. DOI: 10.7164/antibiotics.47.1084.
   PubMed Web of Science ®Google Scholar
• Hashimoto, S. Micafungin: A Sulfated Echinocandin. J. Antibiot. 2009, 62, 27–35. DOI: 10.1038/ja.2008.3.
   PubMed Web of Science ®Google Scholar
• Higashiyama, Y.; Kohno, S. Micafungin: A Therapeutic Review. Expert Rev. Anti. Infect. Ther. 2004, 2, 345–355. DOI: 10.1586/14787210.2.3.345.
   PubMedGoogle Scholar
• Wiederhold, N. P.; Lewis, J. S. The Echinocandin Micafungin: A Review of the Pharmacology, Spectrum of Activity, Clinical Efficacy and Safety. Expert Opin. Pharmacother. 2007, 8, 1155–1166. DOI: 10.1517/14656566.8.8.1155.
   PubMed Web of Science ®Google Scholar
• Briot, T.; Vrignaud, S.; Lagarce, F. Stability of Micafungin Sodium Solutions at Different Concentrations in Glass Bottles and Syringes. Int. J. Pharm. 2015, 492, 137–140. DOI: 10.1016/j.ijpharm.2015.07.019.
   PubMedGoogle Scholar
• Wasmann, R. E.; Muilwijk, E. W.; Burger, D. M.; Verweij, P. E.; Knibbe, C. A.; Brüggemann, R. J. Clinical Pharmacokinetics and Pharmacodynamics of Micafungin. Clin. Pharmacokinet. 2018, 57, 267–286. DOI: 10.1007/s40262-017-0578-5.
   PubMed Web of Science ®Google Scholar
• Arendrup, M. C.; Perlin, D. S.; Jensen, R. H.; Howard, S. J.; Goodwin, J.; Hope, W. Differential in Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida Glabrata Isolates with and without FKS Resistance Mutations. Antimicrob. Agents Chemother. 2012, 56 (5), 2435–2442. DOI: 10.1128/AAC.06369-11.
   Google Scholar
• Chen, S. C. A.; Slavin, M. A.; Sorrell, T. C. Erratum: Echinocandin Antifungal Drugs in Fungal Infections: A Comparison (Drugs (2011) 71: 1 (11-41)). Drugs 2011, 71, 11–41. DOI: 10.2165/11585390-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Hatano, K.; Morishita, Y.; Nakai, T.; Ikeda, F. Antifungal Mechanism of FK463 against Candida albicans and Aspergillus fumigatus. J. Antibiot. 2002, 55, 219–222. DOI: 10.7164/antibiotics.55.219.
   PubMed Web of Science ®Google Scholar
• Satoh, K.; Makimura, K.; Hasumi, Y.; Nishiyama, Y.; Uchida, K.; Yamaguchi, H. Candida auris Sp. Nov., a Novel Ascomycetous Yeast Isolated from the External Ear Canal of an Inpatient in a Japanese Hospital. Microbiol. Immunol. 2009, 53, 41–44. DOI: 10.1111/j.1348-0421.2008.00083.x.
   PubMed Web of Science ®Google Scholar
• Oyake, T.; Kowata, S.; Murai, K.; Ito, S.; Akagi, T.; Kubo, K.; Sawada, K.; Ishida, Y. Comparison of Micafungin and Voriconazole as Empirical Antifungal Therapies in Febrile Neutropenic Patients with Hematological Disorders: A Randomized Controlled Trial. Eur. J. Haematol. 2016, 96, 602–609. DOI: 10.1111/ejh.12641.
   PubMed Web of Science ®Google Scholar
• Kotsopoulou, M.; Papadaki, C.; Anargyrou, K.; Spyridonidis, A.; Baltadakis, I.; Papadaki, H. A.; Angelopoulou, M.; Pappa, V.; Liakou, K.; Tzanetakou, M.; et al. Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study. Infect. Dis. Ther. 2019, 8, 255–268. DOI: 10.1007/s40121-019-0236-3.
   PubMed Web of Science ®Google Scholar
• Pfaller, M. A. Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment. Am. J. Med. 2012, 125, S3–S13. DOI: 10.1016/j.amjmed.2011.11.001.
   PubMed Web of Science ®Google Scholar
• Katiyar, S. K.; Alastruey-Izquierdo, A.; Healey, K. R.; Johnson, M. E.; Perlin, D. S.; Edlind, T. D. Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance. Antimicrob. Agents Chemother. 2012, 56, 6304–6309. DOI: 10.1128/AAC.00813-12.
   PubMed Web of Science ®Google Scholar
• Hiemenz, J.; Cagnoni, P.; Simpson, D.; Devine, S.; Chao, N.; Keirns, J.; Lau, W.; Facklam, D.; Buell, D. Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing. Antimicrob. Agents Chemother. 2005, 49, 1331–1336. DOI: 10.1128/AAC.49.4.1331.
   PubMed Web of Science ®Google Scholar
• Zheng, Y. Z.; Wang, S. Advances in Antifungal Drug Measurement by Liquid Chromatography-Mass Spectrometry. Clin. Chim. Acta 2019, 491, 132–145. DOI: 10.1016/j.cca.2019.01.023.
   PubMed Web of Science ®Google Scholar
• Boonstra, J. M.; Jongedijk, E. M.; Koster, R. A.; Touw, D. J.; Alffenaar, J. W. C. Simple and Robust LC-MS/MS Analysis Method for Therapeutic Drug Monitoring of Micafungin. Bioanalysis 2018, 10, 877–886. DOI: 10.4155/bio-2017-0275.
   PubMed Web of Science ®Google Scholar
• Adaway, J. E.; Keevil, B. G. Therapeutic Drug Monitoring and LC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 883–884, 33–49. DOI: 10.1016/j.jchromb.2011.09.041.
   PubMed Web of Science ®Google Scholar
• Lockhart, S. R.; Zimbeck, A. J.; Baddley, J. W.; Marr, K. A.; Andes, D. R.; Walsh, T. J.; Kauffman, C. A.; Kontoyiannis, D. P.; Ito, J. I.; Pappas, P. G.; Chiller, T. In Vitro Echinocandin Susceptibility of Aspergillus Isolates from Patients Enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob. Agents Chemother. 2011, 55, 3944–3946. DOI: 10.1128/AAC.00428-11.
   PubMed Web of Science ®Google Scholar
• Cushnie, T. P. T.; Lamb, A. J. Antimicrobial Activity of Flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343–356. DOI: 10.1016/j.ijantimicag.2005.09.002.
   PubMed Web of Science ®Google Scholar
• Arendrup, M. C.; Prakash, A.; Meletiadis, J.; Sharma, C.; Chowdhary, A. Comparison of EUCAST and CLSI Reference Microdilution Mics of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values. Antimicrob. Agents Chemother. 2017, 61, 1–10. DOI: 10.1128/AAC.00485-17.
   Web of Science ®Google Scholar
• Ostrosky, E. A.; Mizumoto, M. K.; Lima, M. E. L.; Kaneko, T. M.; Nishikawa, S. O.; Freitas, B. R. M Métodos Para avaliação da atividade antimicrobiana e determinação da concentração mínima inibitória (CMI) de plantas medicinais. Rev. Bras. Farmacogn. 2008, 18, 301–307. DOI: 10.1590/S0102-695X2008000200026.
   Google Scholar
• Jackson, C.; Agboke, A.; Nwoke, V. In Vitro Evaluation of Antimicrobial Activity of Combinations of Nystatin and Euphorbia Hirta Leaf Extract against Candida albicans by the Checkerboard Method. J. Med. Plants Res. 2009, 3, 666–669.
   Google Scholar
• Drago, L.; De Vecchi, E.; Nicola, L.; Gismondo, M. R. In Vitro Evaluation of Antibiotics’ Combinations for Empirical Therapy of Suspected Methicillin Resistant Staphylococcus aureus Severe Respiratory Infections. BMC Infect. Dis. 2007, 7, 1–7. DOI: 10.1186/1471-2334-7-111.
   Web of Science ®Google Scholar
• Mitchell, G.; Lafrance, M.; Boulanger, S.; Séguin, D. L.; Guay, I.; Gattuso, M.; Marsault, É.; Bouarab, K.; Malouin, F. Tomatidine Acts in Synergy with Aminoglycoside Antibiotics against Multiresistant Staphylococcus aureus and Prevents Virulence Gene Expression. J. Antimicrob. Chemother. 2012, 67, 559–568. DOI: 10.1093/jac/dkr510.
   PubMed Web of Science ®Google Scholar
• Ferro, B. E.; van Ingen, J.; Wattenberg, M.; van Soolingen, D.; Mouton, J. W. Time-Kill Kinetics of Slowly Growing Mycobacteria Common in Pulmonary Disease. J. Antimicrob. Chemother. 2015, 70, 2838–2843. DOI: 10.1093/jac/dkv180.
   PubMed Web of Science ®Google Scholar
• Ruiz-Gaitán, A. C.; Cantón, E.; Fernández-Rivero, M. E.; Ramírez, P.; Pemán, J. Outbreak of Candida auris in Spain: A Comparison of Antifungal Activity by Three Methods with Published Data. Int. J. Antimicrob. Agents 2019, 53, 541–546. DOI: 10.1016/j.ijantimicag.2019.02.005.
   PubMed Web of Science ®Google Scholar
• Jeffery-Smith, A.; Taori, S. K.; Schelenz, S.; Jeffery, K.; Johnson, E. M.; Borman, A.; Manuel, R.; Browna, C. S. Candida auris: A Review of the Literature. Clin. Microbiol. Rev 2018, 31, 1–18. DOI: 10.1128/CMR.00029-17.
   Web of Science ®Google Scholar
• Sardi, C. O. J.; Silva, D. R.; Soares Mendes-Giannini, M. J.; Rosalen, P. L. Candida auris: Epidemiology, Risk Factors, Virulence, Resistance, and Therapeutic Options. Microb. Pathog 2018, 125, 116–121. DOI: 10.1016/j.micpath.2018.09.014.
   PubMed Web of Science ®Google Scholar
• Chowdhary, A.; Sharma, C.; Meis, J. F. Candida auris: A Rapidly Emerging Cause of Hospital-Acquired Multidrug-Resistant Fungal Infections Globally. PLoS Pathog. 2017, 13, e1006290–10. DOI: 10.1371/journal.ppat.1006290.
   PubMed Web of Science ®Google Scholar
• Kordalewska, M.; Lee, A.; Park, S.; Berrio, I.; Chowdhary, A.; Zhao, Y.; Perlin, D. S. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris. Antimicrob. Agents Chemother. 2018, 62. 10.1128/AAC.00238-18.
   Web of Science ®Google Scholar
• Fakhim, H.; Chowdhry, A.; Prakash, A.; Vaezi, A.; Dannaoui, E.; Meis, J. F.; Badali, H. In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistent Candida auris. Antimicrob Agents Chemother 2017, 61, 1–5. https://doi/10.1128/AAC.01056-17.
   Web of Science ®Google Scholar
• Chowdhary, A.; Prakash, A.; Sharma, C.; Kordalewska, M.; Kumar, A.; Sarma, S.; Tarai, B.; Singh, A.; Upadhyaya, G.; Upadhyay, S.; et al. A Multicentre Study of Antifungal Susceptibility Patterns among 350 Candida auris Isolates (2009-17) in India: Role of the ERG11 and FKS1 Genes in Azole and Echinocandin Resistance. J. Antimicrob. Chemother 2018, 73, 891–899. DOI: 10.1093/jac/dkx480.
   PubMed Web of Science ®Google Scholar
• Berkow, E. L.; Lockhart, S. R. Activity of Novel Antifungal Compound APX001A against a Large Collection of Candida auris. J. Antimicrob. Chemother. 2018, 73, 3060–3062. DOI: 10.1093/jac/dky302.
   PubMed Web of Science ®Google Scholar
• Ikeda, F.; Saika, T.; Sato, Y.; Suzuki, M.; Hasegawa, M.; Mikawa, T.; Kobayashi, I.; Tsuji, A. Antifungal Activity of Micafungin against Candida and Aspergillus Spp. Isolated from Pediatric Patients in Japan. Med. Mycol. 2009, 47, 145–148. DOI: 10.1080/13693780802262123.
   PubMed Web of Science ®Google Scholar
• Spreghini, E.; Orlando, F.; Tavanti, A.; Senesi, S.; Giannini, D.; Manso, E.; Barchiesi, F. In Vitro and in Vivo Effects of Echinocandins against Candida parapsilosis Sensu Stricto, Candida orthopsilosis and Candida metapsilosis. J. Antimicrob. Chemother. 2012, 67, 2195–2202. DOI: 10.1093/jac/dks180.
   PubMed Web of Science ®Google Scholar
• Gil-Alonso, S.; Quindós, G.; Cantón, E.; Eraso, E.; Jauregizar, N. Killing Kinetics of Anidulafungin, Caspofungin and Micafungin against Candida parapsilosis Species Complex: Evaluation of the Fungicidal Activity. Rev. Iberoam. Micol. 2019, 36, 24–29. DOI: 10.1016/j.riam.2018.12.001.
   PubMed Web of Science ®Google Scholar
• Canton, E.; Peman, J.; Hervas, D.; Espinel-Ingroff, A. Espinel-Ingroff, A. Examination of the in Vitro Fungicidal Activity of Echinocandins against Candida lusitaniae by Time-Killing Methods. J. Antimicrob. Chemother. 2013, 68, 864–868. DOI: 10.1093/jac/dks489.
   PubMed Web of Science ®Google Scholar
• Marcos-Zambrano, L. J.; Escribano, P.; Bouza, E.; Guinea, J. Comparison of the Antifungal Activity of Micafungin and Amphotericin B against Candida tropicalis Biofilms. J. Antimicrob. Chemother. 2016, 71, 2498–2501. DOI: 10.1093/jac/dkw162.
   PubMed Web of Science ®Google Scholar
• Prażyńska, M.; Bogiel, T.; Gospodarek-Komkowska, E. In Vitro Activity of Micafungin against Biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at Different Stages of Maturation. Folia Microbiol. 2018, 63, 209–216. DOI: 10.1007/s12223-017-0555-2.
   PubMed Web of Science ®Google Scholar
• Guembe, M.; Guinea, J.; Marcos-Zambrano, L. J.; Fernández-Cruz, A.; Peláez, T.; Muñoz, P.; Bouza, E. Micafungin at Physiological Serum Concentrations Shows Antifungal Activity against Candida albicans and Candida parapsilosis Biofilms. Antimicrob. Agents Chemother. 2014, 58, 5581–5584. DOI: 10.1128/AAC.02738-14.
   PubMed Web of Science ®Google Scholar
• Matsumoto, S.; Wakai, Y.; Nakai, T.; Hatano, K.; Ushitani, T.; Ikeda, F.; Shuici, T.; Goto, T.; Matsumoto, F.; Kuwahara, S. Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Disseminated Candidiasis and Aspergillosis. Antimicrob. Agents Chemother 2000, 44, 614–618. DOI: 10.1128/AAC.44.3.614-618.2000.
   PubMed Web of Science ®Google Scholar
• Toyoshima, T.; Ishibashi, K. I.; Yamanaka, D.; Adachi, Y.; Ohno, N. Resistance of Aspersillus Fumisatus to Micafungin is Increased by Exogenous β-Glucan. Med. Mycol. J. 2017, 58, 39-E–44.
   Google Scholar
• Al-Hatmi, A. M. S.; Meletiadis, J.; Curfs-Breuker, I.; Bonifaz, A.; Meis, J. F.; De Hoog, G. S. In Vitro Combinations of Natamycin with Voriconazole, Itraconazole and Micafungin against Clinical Fusarium Strains Causing Keratitis. J. Antimicrob. Chemother. 2016, 71, 953–955. DOI: 10.1093/jac/dkv421.
   PubMed Web of Science ®Google Scholar
• Bao, Y. q.; Wan, Z.; Li, R. y. In Vitro Antifungal Activity of Micafungin and Caspofungin against Dermatophytes Isolated from China. Mycopathologia 2013, 175, 141–145. DOI: 10.1007/s11046-012-9571-6.
   PubMed Web of Science ®Google Scholar
• Kumar, S. M. A.; Shetty, A. S. K.; Satyanarayan, N. D. Development and Validation of UV Spectrophotometric Method for the Estimation of Lisinopril in Bulk and Pharmaceutical Formulation. Int. J. Pharm. Sci. Rev. Res. 2014, 25, 257–259.
   Google Scholar
• Gaurav; Kaur, V.; Kumar, A.; Malik, A. K.; Rai, P. K. SPME-HPLC: A New Approach to the Analysis of Explosives. J. Hazard. Mater. 2007, 147 (3), 691–697. DOI: 10.1016/j.jhazmat.2007.05.054.
   Google Scholar
• Siddiqui, M. R.; AlOthman, Z. A.; Rahman, N. Analytical Techniques in Pharmaceutical Analysis: A Review. Arab. J. Chem. 2017, 10, S1409–S1421. DOI: 10.1016/j.arabjc.2013.04.016.
   Web of Science ®Google Scholar
• Riccio, B. F. V.; Fonseca-Santos, B.; Colerato Ferrari, P.; Chorilli, M. Characteristics, Biological Properties and Analytical Methods of Trans -Resveratrol: A Review. Crit. Rev. Anal. Chem. 2019, 0, 1–20. DOI: 10.1080/10408347.2019.1637242.
   Google Scholar
• Hussain, A.; AlAjmi, M. F.; Hussain, I.; Ali, I. Future of Ionic Liquids for Chiral Separations in High-Performance Liquid Chromatography and Capillary Electrophoresis. Crit. Rev. Anal. Chem. 2019, 49, 289–305. DOI: 10.1080/10408347.2018.1523706.
   PubMed Web of Science ®Google Scholar
• Uribe, B.; González, O.; Ba, B. B.; Gaudin, K.; Alonso, R. M. Chromatographic Methods for Echinocandin Antifungal Drugs Determination in Bioanalysis. Bioanalysis 2019, 11, 1215–1228. DOI: 10.4155/bio-2019-0045.
   Web of Science ®Google Scholar
• García-De-Lorenzo, A.; Luque, S.; Grau, S.; Agrifoglio, A.; Cachafeiro, L.; Herrero, E.; Asensio, M. J.; Sánchez, S. M.; Roberts, J. A. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection. Antimicrob. Agents Chemother. 2016, 60, 5914–5921. DOI: 10.1128/AAC.00727-16.
   PubMed Web of Science ®Google Scholar
• Grau, S.; Luque, S.; Campillo, N.; Samsó, E.; Rodríguez, U.; García-Bernedo, C. A.; Salas, E.; Sharma, R.; Hope, W. W.; Roberts, J. A. Plasma and Peritoneal Fluid Population Pharmacokinetics of Micafungin in Post-Surgical Patients with Severe Peritonitis. J. Antimicrob. Chemother. 2015, 70, 2854–2861. DOI: 10.1093/jac/dkv173.
   PubMed Web of Science ®Google Scholar
• Groll, A. H.; Mickiene, D.; Petraitis, V.; Petraitiene, R.; Ibrahim, K. H.; Piscitelli, S. C.; Bekersky, I.; Walsh, T. J. Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits. Antimicrob. Agents Chemother. 2001, 45, 3322–3327. DOI: 10.1128/AAC.45.12.3322-3327.2001.
   PubMed Web of Science ®Google Scholar
• Uranishi, H.; Nakamura, M.; Nakamura, H.; Ikeda, Y.; Otsuka, M.; Kato, Z.; Tsuchiya, T. Direct-Injection HPLC Method of Measuring Micafungin in Human Plasma Using a Novel Hydrophobic/Hydrophilic Hybrid ODS Column. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2011, 879, 1029–1032. DOI: 10.1016/j.jchromb.2011.03.008.
   PubMed Web of Science ®Google Scholar
• Niwa, T.; Yokota, Y.; Tokunaga, A.; Yamato, Y.; Kagayama, A.; Fujiwara, T.; Hatakeyama, J.; Anezaki, M.; Ohtsuka, Y.; Takagi, A. Tissue Distribution after Intravenous Dosing of Micafungin, an Antifungal Drug, to Rats. Biol. Pharm. Bull. 2004, 27, 1154–1156. DOI: 10.1248/bpb.27.1154.
   PubMed Web of Science ®Google Scholar
• Mochizuki, K.; Suemori, S.; Udo, K.; Komori, S.; Ohkusu, K.; Yamada, N.; Ogura, S. Intraocular Penetration of Micafungin in Patient with Candida albicans Endophthalmitis. J. Ocul. Pharmacol. Ther. 2011, 27, 531–533. DOI: 10.1089/jop.2011.0026.
   PubMed Web of Science ®Google Scholar
• Tabata, K.; Katashima, M.; Kawamura, A.; Kaibara, A.; Tanigawara, Y. Population Pharmacokinetic Analysis of Micafungin in Japanese Patients with Fungal Infections. Drug Metab. Pharmacokinet. 2006, 21, 324–331. DOI: 10.2133/dmpk.21.324.
   PubMed Web of Science ®Google Scholar
• Suzuki, T.; Uno, T.; Chen, G.; Ohashi, Y. Ocular Distribution of Intravenously Administered Micafungin in Rabbits. J. Infect. Chemother. 2008, 14, 204–207. DOI: 10.1007/s10156-008-0612-5.
   PubMedGoogle Scholar
• Nakagawa, S.; Kuwabara, N.; Kobayashi, H.; Shimoeda, S.; Ohta, S.; Yamato, S. Simple Column-Switching HPLC Method for Determining Levels of the Antifungal Agent Micafungin in Human Plasma and Application to Patient Samples. Biomed. Chromatogr. 2013, 27, 551–555. DOI: 10.1002/bmc.2822.
   PubMed Web of Science ®Google Scholar
• Shimoeda, S.; Ohta, S.; Kobayashi, H.; Saitou, H.; Kubota, A.; Yamato, S.; Shimada, K.; Sasaki, M.; Kawano, K. Analysis of the Blood Level of Micafungin Involving Patients with Hematological Diseases: New Findings regarding Combination Therapy with Tacrolimus. Biol. Pharm. Bull. 2005, 28, 477–480. DOI: 10.1248/bpb.28.477.
   PubMed Web of Science ®Google Scholar
• Shimoeda, S.; Ohta, S.; Kobayashi, H.; Yamato, S.; Sasaki, M.; Kawano, K. Effective Blood Concentration of Micafungin for Pulmonary Aspergillosis. Biol. Pharm. Bull. 2006, 29, 1886–1891. DOI: 10.1248/bpb.29.1886.
   PubMed Web of Science ®Google Scholar
• Maseda, E.; Grau, S.; Villagran, M.-J.; Hernandez-Gancedo, C.; Lopez-Tofiño, A.; Roberts, J. A.; Aguilar, L.; Luque, S.; Sevillano, D.; Gimenez, M.-J.; Gilsanz, F. Micafungin Pharmacokinetic/Pharmacodynamic Adequacy for the Treatment of Invasive Candidiasis in Critically Ill Patients on Continuous Venovenous Haemofiltration. J. Antimicrob. Chemother. 2014, 69, 1624–1632. DOI: 10.1093/jac/dku013.
   PubMed Web of Science ®Google Scholar
• Kishino, S.; Ohno, K.; Shimamura, T.; Furukawa, H.; Todo, S. Optimal Prophylactic Dosage and Disposition of Micafungin in Living Donor Liver Recipients. Clin. Transplant. 2004, 18, 676–680. DOI: 10.1111/j.1399-0012.2004.00272.x.
   PubMed Web of Science ®Google Scholar
• Tenorio-Cañamás, T.; Grau, S.; Luque, S.; Fortún, J.; Liaño, F.; Roberts, J. A. Pharmacokinetics of Micafungin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis with High Cutoff Membranes. Ther. Drug Monit. 2019, 41, 376–382. DOI: 10.1097/FTD.0000000000000595.
   PubMed Web of Science ®Google Scholar
• Bellmann, R.; Smuszkiewicz, P. Pharmacokinetics of Antifungal Drugs: Practical Implications for Optimized Treatment of Patients. Infection 2017, 45, 737–779. DOI: 10.1007/s15010-017-1042-z.
   PubMed Web of Science ®Google Scholar
• Maseda, E.; Grau, S.; Luque, S.; Castillo-Mafla, M. P.; Suárez-de-la-Rica, A.; Montero-Feijoo, A.; Salgado, P.; Gimenez, M. J.; García-Bernedo, C. A.; Gilsanz, F. Population Pharmacokinetics/Pharmacodynamics of Micafungin against Candida Species in Obese, Critically Ill, and Morbidly Obese Critically Ill Patients. Crit. Care 2018, 22, 1–9. DOI: 10.1186/s13054-018-2019-8.
   PubMed Web of Science ®Google Scholar
• Petraitiene, R.; Petraitis, V.; Hope, W. W.; Walsh, T. J. Intermittent Dosing of Micafungin is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits. Clin. Infect. Dis. 2015, 61, S643–S651. DOI: 10.1093/cid/civ817.
   PubMed Web of Science ®Google Scholar
• Zhu, S.; Meng, X.; Su, X.; Luo, Y.; Sun, Z. Development and Validation of a Stability-Indicating High Performance Liquid Chromatographic (HPLC) Method for the Determination of Related Substances of Micafungin Sodium in Drug Substances. IJMS. 2013, 14, 21202–21214. DOI: 10.3390/ijms141121202.
   Google Scholar
• Cangemi, G.; Barco, S.; Bandettini, R.; Castagnola, E. Quantification of Micafungin in Human Plasma by Liquid Chromatography- Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2014, 406, 1795–1798. DOI: 10.1007/s00216-013-7590-x.
   PubMedGoogle Scholar
• Farowski, F.; Cornely, O. A.; Vehreschild, J. J.; Bauer, T.; Hartmann, P.; Steinbach, A.; Vehreschild, M. J. G. T.; Scheid, C.; Müller, C. Intracellular Concentrations of Micafungin in Different Cellular Compartments of the Peripheral Blood. Int J Antimicrob Agents 2012, 39, 228–231. DOI: 10.1016/j.ijantimicag.2011.11.006.
   PubMed Web of Science ®Google Scholar
• Martens-Lobenhoffer, J.; Rupprecht, V.; Bode-Böger, S. M. Determination of Micafungin and Anidulafungin in Human Plasma: UV- or Mass Spectrometric Quantification? J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2011, 879, 2051–2056. DOI: 10.1016/j.jchromb.2011.05.033.
   PubMed Web of Science ®Google Scholar
• Benjamin, D. K. Jr.; Smith, P. B.; Arrieta, A.; Castro, L.; Sanchez, P.; Kaufman, D.; Arnold, L. J.; Kovanda, L. L.; Sawamoto, T.; Buell, D.; et al. Safety and Pharmacokinetics os Repeat-Dose Micafungin in Young Infants. Clin. Pharmacol. Ther. 2010, 87, 93–99. DOI: 10.1038/clpt.2009.200.
   PubMed Web of Science ®Google Scholar
• Smith, P. B.; Walsh, T. J.; Hope, W.; Arrieta, A.; Takada, A.; Kovanda, L. L.; Kearns, G. L.; Kaufman, D.; Sawamoto, T.; Buell, D. N.; et al. Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates. Pediatr. Infect. Dis. J. 2009, 28, 412–415. DOI: 10.1097/INF.0b013e3181910e2d.
   PubMed Web of Science ®Google Scholar
• Nageswara Rao, R.; Nagaraju, V. An Overview of the Recent Trends in Development of HPLC Methods for Determination of Impurities in Drugs. J. Pharm. Biomed. Anal 2003, 33, 335–377. DOI: 10.1016/S0731-7085(03)00293-0.
   PubMed Web of Science ®Google Scholar
• Joshi, S.; Majmudar, F.; Vyas, N. Development and Validation of Analytical Method for Determination of Micafungin and Its Related Substances in Bulk by Rp-Uplc. Int. J. Pharm. Sci. Res. 2016, 7, 1211–1218. DOI: 10.13040/IJPSR.0975-8232.6(5).2228-39.
   Web of Science ®Google Scholar
• Ishikawa-Ankerhold, H. C.; Ankerhold, R.; Drummen, G. P. C. Advanced Fluorescence Microscopy Techniques-FRAP, FLIP, FLAP, FRET and FLIM. Molecules 2012, 17, 4047–4132. DOI: 10.3390/molecules17044047.
   PubMed Web of Science ®Google Scholar
• Brandt, E. E.; Masta, S. E. Females Are the Brighter Sex: Differences in External Fluorescence across Sexes and Life Stages of a Crab Spider. PLoS One 2017, 12, e0175667–18. DOI: 10.1371/journal.pone.0175667.
   PubMed Web of Science ®Google Scholar
• Lagorio, M. G.; Cordon, G. B.; Iriel, A. Reviewing the Relevance of Fluorescence in Biological Systems. Photochem. Photobiol. Sci. 2015, 14, 1538–1559. DOI: 10.1039/C5PP00122F.
   PubMed Web of Science ®Google Scholar
• Naderi, J.; Giles, C.; Saboohi, S.; Griesser, H. J.; Coad, B. R. Surface Coatings with Covalently Attached Anidulafungin and Micafungin Prevent Candida albicans Biofilm Formation. J. Antimicrob. Chemother. 2019, 74, 360–364. DOI: 10.1093/jac/dky437.
   PubMed Web of Science ®Google Scholar
• Nagy, F.; Tóth, Z.; Bozó, A.; Czeglédi, A.; Rebenku, I.; Majoros, L.; Kovács, R. Fluconazole is Not Inferior than Caspofungin, Micafungin or Amphotericin B in the Presence of 50% Human Serum against Candida albicans and Candida parapsilosis Biofilms. Med. Mycol. 2019, 57, 573–581. DOI: 10.1093/mmy/myy108.
   Web of Science ®Google Scholar
• Borg-Von Zepelin, M.; Zaschke, K.; Gross, U.; Monod, M.; Müller, F. M. C. Effect of Micafungin (FK463) on Candida Albicans Adherence to Epithelial Cells. Chemotherapy 2002, 48, 148–153. DOI: 10.1159/000064921.
   PubMed Web of Science ®Google Scholar
• Lewis, R. E.; Kontoyiannis, D. P. Micafungin in Combination with Voriconazole in Aspergillus Species: A Pharmacodynamic Approach for Detection of Combined Antifungal Activity in Vitro. J. Antimicrob. Chemother. 2005, 56, 887–892. DOI: 10.1093/jac/dki343.
   PubMed Web of Science ®Google Scholar
• Watabe, E.; Nakai, T.; Matsumoto, S.; Ikeda, F.; Hatano, K. Killing Activity of Micafungin against Aspergillus Fumigatus Hyphae Assessed by Specific Fluorescent Staining for Cell Viability. Antimicrob. Agents Chemother. 2003, 47, 1995–1998. DOI: 10.1128/AAC.47.6.1995-1998.2003.
   PubMed Web of Science ®Google Scholar
• Peter, T.; Bissinger, R.; Signoretto, E.; Mack, A. F.; Lang, F. Micafungin-Induced Suicidal Erythrocyte Death. Cell. Physiol. Biochem. 2016, 39, 584–595. DOI: 10.1159/000445650.
   PubMedGoogle Scholar
• Honda, S.; Taga, A. Studies of Carbohydrate-Protein Interaction by Capillary Electrophoresis. Meth. Enzymol. 2003, 362, 434–454. DOI: 10.1016/S0076-6879(03)01030-9.
   PubMed Web of Science ®Google Scholar
• Stellwagen, N. C. Electrophoresis of DNA in Agarose Gels, Polyacrylamide Gels and in Free Solution. Electrophoresis 2009, 30 (SUPPL. 1), 188–195. DOI: 10.1002/elps.200900052.
   Google Scholar
• Kitahashi, T.; Furuta, I. Analysis of Micafungin in Serum by Capillary Zone Electrophoresis. J. Chromatogr. Sci. 2007, 45, 28–32. DOI: 10.1093/chromsci/45.1.28.
   PubMed Web of Science ®Google Scholar
• Kurien, B. T.; Igoe, A.; Scofield, R. H. Curcumin/Turmeric as an Environment-Friendly Stain for Proteins on Acrylamide Gels. Polyphenols Human Health Dis. 2013, 1, 779–884. DOI: 10.1016/B978-0-12-398456-2.00060-8.
   Google Scholar
• Kida, A.; Ikeda, T.; Seto, H.; Iida, Y. Evaluation of Conventional Antifungal Agents against Recombinant Yeast Overexpressing β-1,3-Glucanase. Yakugaku Zasshi 2018, 138, 837–842. DOI: 10.1248/yakushi.17-00197.
   PubMed Web of Science ®Google Scholar